Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 13 X users

Citations

dimensions_citation: 124 Dimensions

Readers on

mendeley: 111 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 124 publications that cite this research output.

124

The most recent citing publications are shown below. View all 124 publications that cite this research output on Dimensions.

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan

Article in Cureus (April 2024)

Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma

Article in Translational Oncology (February 2024)

Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade

Article in Journal for ImmunoTherapy of Cancer (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.